跳至主要内容
临床试验/NCT01134445
NCT01134445终止4 期

Prospective, International Multi-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of the DePuy PROXIMA™ Hip in Subjects With Indications Suitable for a Primary Total Hip Arthroplasty

DePuy International4 个研究点 分布在 4 个国家目标入组 42 人开始时间: 2010年2月1日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
42
试验地点
4
主要终点
Kaplan-Meier survivorship calculated at the five-year time-point

研究概览

简要总结

The purpose of this study is to monitor the performance of the DePuy PROXIMA™ hip in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects between 18 and 70 years of age.
  • Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and agree to return to the hospital for all the required post-operative follow-ups.
  • Subjects who are scheduled to undergo a primary THR whom the surgeon considers to be suitable for the DePuy PROXIMATM hip femoral prosthesis.

排除标准

  • Subjects with active local or systemic infection
  • Subjects with loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified.
  • Subjects with poor bone quality, such as osteoporosis, where, in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of fracture of the femoral shaft and/or the lack of adequate bone to support the implant(s).
  • Subjects with Charcot's or Paget's disease.
  • Subjects with hip dysplasia with severe neck anteversion or severe dysplasia of the proximal femur.
  • Subjects with severe osteoporosis.
  • Subjects with previous proximal femoral fractures.
  • Subjects who, in the opinion of the Investigator, have an existing condition/co-morbidity or infection that would compromise their long-term participation and follow-up in this study.
  • Women who are pregnant.
  • Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
  • Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
  • Subjects who are currently involved in any injury litigation claims.
  • Subjects for whom the surgical procedure is a revision of a previous THR, hemi-arthroplasty or hip resurfacing
  • Subjects who have previously undergone osteotomy or arthrodesis of the hip.
  • Subjects undergoing a simultaneous bilateral hip operation.
  • Subjects undergoing the second stage of a staged bilateral for whom the contralateral hip is part of this clinical investigation.
  • Subjects undergoing the second stage of a staged bilateral for whom the contralateral hip was implanted less than six months previously or is not performing satisfactorily

结局指标

主要结局

Kaplan-Meier survivorship calculated at the five-year time-point

时间窗: 5yrs post surgery

次要结局

  • Annual Kaplan-Meier survivorship calculations(15yrs post-surgery)
  • Harris Hip Score(15yrs post-surgery)
  • Oxford Hip Score(15yrs post-surgery)
  • UCLA Activity Score(15yrs post-surgery)
  • Hip Outcome Score(15yrs post-surgery)
  • EuroQol EQ-5D(15yrs post-surgery)
  • Radiographic Analysis(15 yrs post-surgery)

研究者

发起方
DePuy International
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验